Montreal Cognitive Assessment (MoCA): Clinical Implications in Early Alzheimer’s Disease

Life Sciences, Healthcare, Fundamental Research,
  • Wednesday, June 23, 2021 | 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central)
  • 60 min

The Montreal Cognitive Assessment Test (MoCA) was created by neurologist Dr. Ziad Nasreddine in 1996, as a multi-domain cognitive screening test to help health professionals detect Mild Cognitive Impairment (MCI). In its first published validation study in 2005, while the test maintained high specificity (87%), its sensitivity to detect MCI was 90% compared to the MMSE which was 18%. The test was then validated in over 20 neurological and medical conditions, and translated into 70 languages and dialects, used in over 2,000 published studies, and was cited 13,000 times in peer reviewed journals. It is currently used in over 200 countries.

Register for this webinar, which will summarise the main validation study, describe newer versions such as the electronic app, explain the importance of the training and certification program, show clinical cases, use in clinical trials and give a brief outline of future developments.

Speakers

http://Ziad%20Nasreddine,%20Neurologist

Ziad Nasreddine MD FRCP(C), Neurologist, University of Sherbrooke

Ziad Nasreddine graduated from Medical School and Neurology from the University of Sherbrooke. He is certified by the Medical Board of California, and by the American Board if Psychiatry and Neurology. He completed a post-doctorate fellowship in Neurobehavior at UCLA, with Dr. Jeffrey Cummings. He is the recipient of the Arista Sunlife Award of Excellence in the category of Young Quebec Professional. He is actively involved in clinical research in Alzheimer’s disease and has created and developed the Montreal Cognitive Assessment, the MoCA test, which is translated to 70 languages and dialects and now used in 200 countries around the world. The test was recently selected by the White House to assess the cognitive functions of President Donald Trump. He is affiliated with Charles LeMoyne Hospital. He is Assistant Clinical Professor in Neurology at the University of Sherbrooke, and is the founder and Director of the MoCA Clinic and Institute.

Message Presenter

Carter Cassedy, Senior Client Services Associate, Author Collaboration Unit, Mapi Research Trust

Carter Cassedy is a Senior Client Services Associate with Mapi Research Trust’s Author Collaboration Unit. Prior to his work with the ACU he was a project manager in ICON Language Services’ Linguistic Validation team. As a member of that team he published several posters on linguistic validation methodology in outcomes-related conferences. He is a certified Localization Project Manager. He graduated from University of London, School of Oriental and African Studies with an MA in Linguistics.

Message Presenter

Who Should Attend?

This webinar will appeal to:

  • Healthcare Professionals
  • Researchers
  • Academia
  • Pharmaceutical Personnel
  • Those Interested in Cognitive Impairment, Assessment and Screening

Xtalks Partner

Mapi Research Trust

Mapi Research Trust is the official licensor and distributor of over 600 COAs, on behalf of their developers and copyright owners. Please visit our catalog to access the complete list of COAs managed by Mapi Research Trust, or visit our website for additional information on our services to developers and copyright owners.

Media Partner

The original site for employees in the pharma, medical, diagnostic and related industries.  Our hand-curated daily news feed and active message forums will keep you informed.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account